We are live on ! Find out more
DS

David Shaw D.E. Shaw & Co

AUM $210B
1-Year Est. Return 57.28%
 

David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.

This Fund
S&P 500
This Quarter Est. Return
+8.35%
1 Year Est. Return
+57.28%
3 Year Est. Return
+174.65%
5 Year Est. Return
+213.13%
10 Year Est. Return
+910.08%
AUM
$116B
AUM Growth
+$12.3B
Cap. Flow
-$2.57B
Cap. Flow %
-2.21%
Top 10 Hldgs %
9.91%
Holding
5,208
New
1,193
Increased
1,491
Reduced
1,580
Closed
489

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$672M
2
MRK icon
Merck
MRK
+$476M
3
META icon
Meta Platforms (Facebook)
META
+$392M
4
MCD icon
McDonald's
MCD
+$372M
5
WFC icon
Wells Fargo
WFC
+$357M

Sector Composition

Rank Sector Weight
1 Technology 16%
2 Consumer Discretionary 9.85%
3 Communication Services 7.8%
4 Healthcare 7.67%
5 Financials 5.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EXP icon
4651
Eagle Materials
EXP
$6.35B
-4,480
Closed -$602K
FCEL icon
4652
PUT
FuelCell Energy
FCEL
$1.56B
-7,880
Closed -$3.41M
FFWM
4653
DELISTED
First Foundation Inc
FFWM
-37,172
Closed -$872K
FICO icon
4654
Fair Isaac
FICO
$25.3B
-7,373
Closed -$3.73M
FITB
4655
CALL
Fifth Third Bancorp
FITB
$49.7B
-5,600
Closed -$210K
FIVE icon
4656
PUT
Five Below
FIVE
$13.8B
-20,000
Closed -$3.82M
FLGT icon
4657
CALL
Fulgent Genetics
FLGT
$548M
-20,000
Closed -$1.93M
FLGT icon
4658
Fulgent Genetics
FLGT
$548M
-5,905
Closed -$571K
FLGT icon
4659
PUT
Fulgent Genetics
FLGT
$548M
-20,100
Closed -$1.94M
FLIC
4660
DELISTED
First of Long Island Corp
FLIC
-13,681
Closed -$291K
FLNT
4661
Fluent
FLNT
$130M
-3,477
Closed -$86K
FMS icon
4662
Fresenius Medical Care
FMS
$12.5B
-26,363
Closed -$972K
FNF icon
4663
Fidelity National Financial
FNF
$12.7B
-107,474
Closed -$4.2M
FPH icon
4664
Five Point Holdings
FPH
$369M
-25,704
Closed -$194K
FRO icon
4665
PUT
Frontline
FRO
$9.72B
-50,000
Closed -$358K
FTNT icon
4666
Fortinet
FTNT
$113B
-205,280
Closed -$8.76M
FTNT icon
4667
PUT
Fortinet
FTNT
$113B
-60,000
Closed -$2.21M
FUL icon
4668
H.B. Fuller
FUL
$3.16B
-22,447
Closed -$1.41M
GES
4669
PUT
DELISTED
Guess Inc
GES
-40,000
Closed -$940K
GERN icon
4670
Geron
GERN
$977M
-106,476
Closed -$168K
GFI icon
4671
Gold Fields
GFI
$42.8B
-22,166
Closed -$210K
GILD icon
4672
Gilead Sciences
GILD
$181B
-609,167
Closed -$40.7M
GLNG icon
4673
Golar LNG
GLNG
$5.31B
-15,367
Closed -$157K
GNE icon
4674
Genie Energy
GNE
$395M
-12,516
Closed -$79K
GNK icon
4675
Genco Shipping & Trading
GNK
$1.16B
-135,234
Closed -$1.36M

Similar funds

David Shaw's Q2 2021 Portfolio in Review

As of Q2 2021, David Shaw held 5,208 positions worth $116B, up 12% from $104B the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.

David Shaw's Q2 2021 filing shows 1,193 new, 1,491 increased, 1,580 reduced and 489 closed positions. Its largest new stake was Weatherford International: 4,894,906 shares worth $89.1M. The largest sale was Microsoft, an estimated $672M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Communication Services.

  • David Shaw's largest Q2 2021 buy was Weatherford International: 4,894,906 shares worth $89.1M.
  • David Shaw added most to Just Eat Takeaway.com N.V. American Depositary Shares in Q2 2021, an estimated $700M increase.
  • David Shaw's biggest Q2 2021 reduction was Microsoft, cutting an estimated $672M.
  • David Shaw fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $131M.
  • David Shaw's ten largest holdings make up 9.9% of its $116B portfolio in Q2 2021.
  • David Shaw opened 1,193 new positions and closed 489 in Q2 2021.
  • David Shaw's portfolio value rose 12% quarter-over-quarter to $116B.

Based on D.E. Shaw & Co's 13F filing for Q2 2021, filed 16 Aug 2021.